ASND Research and Charts

ASND - Ascendis Pharma A/S ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 172.60	Change ⇑ +0.38 (+0.22%)	Volume 420,195
	Open 172.22	High 174.31	Low 169.21

8EMA (Daily) 173.51	40EMA (Daily) 168.19	50EMA (Daily) 166.41	STO (Daily) 51.047	MACD Hist (Daily) -1.232
8EMA (Weekly) 169.200	40EMA (Weekly) 151.56	50EMA (Weekly) 148.29	STO (Weekly) 83.230	MACD Hist (Weekly) 1.775


Company Profile
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.